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Abstract 
 The aim of the study was to measure HIV prevalence and risk behaviour in 185 Irish 
Intravenous Drug Misusers. Information was obtained by application of a standardised WHO 
questionnaire covering HIV risk behaviour in the preceding 6 months. HIV serostatus was 
obtained by saliva/blood sample testing. 
 One hundred and 3 (55.7 per cent) shared and 114 (61.6 per cent) lent used injecting 
equipment in the previous 6 months. 97 (94.2 per cent) of those who shared always cleaned the 
needles before use but only 48 (49.5 per cent) of these always cleaned in an efficient manner. 
 One hundred and 14 (79.2 per cent) males and 28 (68.3 per cent) females reported 
heterosexual activity in the preceding 6 months. On examination sexual risk behaviour was 
found to be high. 50.5 per cent of males and 63 per cent of females never used condoms with 
regular partners. 32.6 per cent of males never used condoms with casual partners. 
 The large majority of partners of male I.D.U’.s (both regular and casual) were non 
injectors. Therefore there is potential for sexual spread of HIV into the non-injecting 
heterosexual population. Conversely the vast majority of partners of female IDU’s were 
injectors. This suggests that female IDU’s are at higher risk of HIV infection than their male 
counterparts. 
 HIV prevalence in the study group was 8.4 per cent. Implications of results for future 
intervention are discussed. 
Introduction 
In Europe injecting drug users are the largest group of registered cases of Aids1. While HIV 
infection among Intravenous Drug Users is mainly transmitted through syringe sharing it is 
primarily a sexually transmitted disease2. 
 Drug injectors have reduced their sharing of injecting equipment in response to a wide 
variety of Aids prevention programmes including syringe exchanges and substance misuse 
treatment programmes but changing sexual risk behaviour has been considerably more difficult3. 
Various studies have shown a reduction in needle sharing and intravenous use over time4,5,6,7. 
Sexual behaviour does not appear to have changed with the advent of H.I.V, with the majority of 
injecting drug users being-sexually active and condom use remaining low8,9,10. Limited changes in 
sexual risk behaviour have been noted though in some studies11,12. 
 A high proportion of drug injector’s partners (especially partners of male injectors) are 
non-injectors and concern has been raised about the significant sexual risk of H.I.V. transmission 
to this group and the lack of care/counselling this group is receiving13,9. 
 In the Republic of Ireland Intravenous Drug Abuse is the largest risk category for HIV with 
49 per cent of cumulative HIV positive cases being injecting drug users14. There has been a major 
expansion of treatment services in the 1990s in Ireland upon the publication of The Government 
Strategy to Prevent Drug Misuse 199115 and National Aids Strategy Committee report 199216. 
Treatment places and syringe exchanges have increased and there is easy availability of condoms. 
In 1991 Johnson found a HIV prevalence of 14.8 per cent amongst attenders at a Dublin needle 
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 prevalence figures in the British Isles are 12.8 per cent in London, 1.8 per cent in Glasgow and 
20.4 per cent in Edinburgh8,18. 
 
 This study reports on HIV prevalence and injecting and sexual risk behaviour in a group of 
Dublin I.D.U.’s. Implications and problems for future intervention are discussed. 
Method 
 The study was undertaken as part of an ongoing World Health Organisation (WHO) multi-
national research initiative. 
 The sample comprised 185 intravenous drug users (I.D.U.) obtained from a variety of 
different sources. An I.D.U. was defined as having injected drugs at least once in the 2 months 
before interview. To ensure that a representative sample of intravenous drug users was obtained, 
the sample consisted both of in-treatment and out of treatment groups. I.D.U.’s were recruited 
irrespective of H.I.V. status. 
 The subjects recruited were then interviewed by a trained interviewer using a standardised 
WHO questionnaire. The interviews lasted approximately 90 minutes and all questions related to 
behaviour in the proceeding 6 months. Questions concerned HIV risk behaviour in terms of 
needle sharing (i.e. using a needle or syringe already used by somebody else), lending, cleaning, 
sexual behaviour, condom use and sexual partners. 
 Blood and saliva samples were obtained for the purposes of anonymous HIV testing. 
Informed consent was obtained from all subjects for participation in the study. 
Results 
 Sample characteristics – The 185 subjects recruited comprised 100 “in treatment” and 85 
“out of treatment” individuals. In terms of gender, 144 (77.8 per cent) were male and 41 (22.2 per 
cent) female. Their mean age was 24 yr and mean age of first injecting was 18 yr of age. One 
hundred and 70 (91.9 per cent) were unemployed, 109 (58.9 per cent) relied mainly on illegal 
income to support their habit and 124 (67.0 per cent) had a history of imprisonment. 
 Needle &. Syringe Sharing – Over half the respondents, 103 (55.7 per cent), reported 
sharing used injecting equipment in the proceeding 6 months. A supplementary question then 
asked about lending injecting equipment and 114 (61.6 per cent) of the subjects reported giving 
their own used needle to another I.D.U. within the last 6 months. 
 For those I.D.U. who had shared used injecting equipment additional questions were asked 
related to the frequency of sharing and cleaning such needles before use (Table I) 
TABLE I 
Frequency of sharing used equipment and cleaning equipment before use 
N = 103 
How often shared used equipment 
 N % 
Always 4 3.9 
Usually 11 10.7 
Half the time 18 17.5 
Sometimes 69 67.0 
D.K/D.R. 1 1.0 
How often cleaned before use 
 N % 
Always 97 94.2 
Usually 2 1.9 
Half the time 0 0.0 
Sometimes 3 2.9 
Never 1 1.0 
D.K. 0 0.0 
 Thus 97 (94.2 per cent) of I.D.U.’s who shared injecting equipment reported that they 
always cleaned it prior to use. However 49 (50.5 percent) of these I.D.U’s were not always 
cleaning in an efficient manner (i.e. bleach and boiling water). See Table II. 
TABLE II 
Cleaning method for those who always clean 
N=97 
 N % 
Always Efficient 48 49.5 
Not Always Efficient 49 50.5 
 Sexual Risk Behaviour – Respondents were asked about sexual activity in the preceding 6 
months. From the 144 males, 114 (79.2per cent) reported heterosexual activity and 30 (20.8 per 
cent) reported no sexual activity. For the 41 females 28 (68.3 per cent) reported heterosexual 
activity, 12 (29.3 per cent) reported no activity and 1 (2.4 per cent) reported prostitution. There 
was no reported homosexual activity. 
 Those subjects reporting heterosexual activity were then asked about their partners, 
whether they were regular or casual. A regular partner was defined as someone with whom they 
had been in a sexual relationship with for at least three months. Ninety-two (80.7 per cent) males 
had one regular partner in the preceding 6 months and 1 (0.9 per cent) male had two regular 
partners. Forty-six (40.4 per cent) males had casual partner(s) in the preceding 6 months. Twenty-
six (92.9 per cent) females had one regular partner in the preceding 6 months and 4 (14.3 per 
cent) had casual partner(s) 
Condom Use 
 Table III shows condom use with partners. 50.5 per cent of males and 63 per cent of 
females never used condoms with regular partners. Only 20.4 per cent of males always used 
condoms with regular partners. 
 When asked about condom use with casual partners the rate was somewhat improved. 32.6 
per cent of males never used condoms with casual partners and 23.9 per cent always used 
condoms with casual partners. However for the female I.D.U’s too much cannot be extrapolated 
from the data as only 4 females reported casual partners. 
Injecting Status of Sexual Partner 
 In looking at injecting status of sexual partner, information was only available on 104 of 
the 114 males who were heterosexually active and 26 out of the 29 females who were 
heterosexually active. 
 Out of these, 83 males and 24 females reported regular partners in the proceeding 6 months 
(1 male had 2 regular partners). 23.8 per cent (20 out of 84) of the regular partners of male IDU’s 
were injectors while 91.7 per cent (22 out of 24) of the regular partners of female IDU’s were 
injectors. Female IDU’s were significantly more likely to have a regular partner who also injects 
(X=39.6 P<0.01) 
 Turning our attention to casual sexual partners in the proceeding 6 months, 41 males and 4 
females reported casual partners. In view of the small numbers of females reporting casual 
partners little information can be obtained from comparing the male and female I.D.U.’s. 
However for the 41 male I.D.U.’s, 13 had injecting casual partners and 34 had non injecting 
casual partners (patients may have more than one casual partner). 
 From this data we therefore observe that the male intravenous drug users are commonly 
involved in sexual relationships with non-injecting partners on both a regular and a casual basis. 
The female is much less likely to have a regular partner who does not inject drugs. 
 One hundred and eighty out of 185 IDU’s agreed to HIV testing. The HIV prevalence was 
8.4 per cent. 
TABLE III 
Condom Use with partners 
 Regular Casual 
 Male (N=93) Female (N=27)* Male (N=46) Female (N=4) 
Frequency N % N % N % N % 
Always 19 20.4 4 14.8 11 23.9 2 50 
Usually 5 5.4 0 00.0 5 10.9 0 0 
Half the time 4 4.3 0 00.0 6 13.0 0 0 
Sometimes 18 19.4 6 22.2 9 19.6 0 0 
Never 47 50.5 17 63.0 15 32.6 2 50 
* Includes one prostitute with regular partner 
Discussion 
 Numerous studies have shown a reduction in injecting risk behaviour in I.D.U.’s since the 
recognition of HIV/ AIDS. The results of this study still show high levels of sharing and lending 
of used injecting equipment in the previous 6 months. It is difficult to compare these results with 
Johnson (1991) as the time period over which risk behaviour was assessed was shorter. Their 
study noted that 47.4 per cent lent used needle and 48.7 per cent shared used needles in the 
previous 28 days17. 
 To their credit almost all I.D.U’s who shared used equipment attempted to clean it before 
use but it is of concern that only approximately half always cleaned efficiently. A similar trend 
was noted in Glasgow and London I.D.U.’s8. Because of the high level of inefficiency in cleaning 
we would feel that I.D.U’s should only receive one message regarding reducing injecting risk 
behaviour i.e. only use new injecting equipment. 
 As in previous studies heterosexual activity is high with the majority of I.D.U.’s being 
sexually active in the preceding 6 months9. Condom use was low, particularly with regular 
partners. Half the males and almost two thirds of females never used condoms with their regular 
partners while a third of males never used condoms, .with casual partners. Therefore the potential 
for sexual transmission of HIV is high. 
 Previous studies have shown low condom use in I.D.U’s and noted that changing sexual 
risk behaviour has been more difficult to achieve than needle sharing behaviour2. Johnson et al 
found that in Dublin needle exchange attenders in 1991 29.5 per cent never used condoms and 
23.9 per cent always used condoms in heterosexual activity in the previous 28 days17. 
 A large majority of the partners of male I.D.U’s (both casual and regular partners) were 
non injectors. There is therefore the potential for sexual mixing ofI.D.U.’s and the non injecting 
heterosexual population where unprotected sex may be the only risk factor. Moss suggested that 
drug users are the source of at least three quarters of cases of heterosexual transmission of H.I.V. 
in the U.S.19 In the U.K. a drug injecting partner is reported in over 60 per cent of first generation 
cases of heterosexual transmission of H.I.V.20. With low condom use in the group as a whole one 
has to be concerned with the potential of H.I.V. transmission to the non-injecting heterosexual 
population (especially females) in Ireland. Previous research has highlighted this concern8. The 
high levels of heterosexual risk behaviour and high numbers of non- injecting partners has 
prompted much comment in recent times and it has been suggested that drug treatment agencies 
are not fully addressing sexual risk behaviour in I.D.U’s and partners and therefore a broader 
outreach approach should be implemented2,9. White pointed out that non using partners of 
I.D.U.’s do not generally receive care from drug treatment or other agencies and it is therefore 
likely that issues surrounding their sexual health are not addressed13. It would be important to 
debate the situation within Irish treatment settings. 
 Male injectors are likely to be in a sexual relationship with non injecting women while 
injecting women are more likely to be in a relationship with injecting men2. The results of this 
study are in keeping with this. This suggests that female I.D.U’s are at greater HIV risk than their 
male counterparts21. Saxon noted that having a sexual partner who is also an I.D.U. increases the 
risk for I.V. use and sharing equipment and makes risk reduction less likely5. Therefore in 
treatment and counselling female I.D.U.’s should perhaps be focused upon as a group particularly 
prone to HIV risk behaviour. 
 The HIV prevalence in the group was 8.4 per cent which is lower than the figure of 14.8 
per cent obtained by Johnson in Dublin needle exchange attenders in 199117. One reason for this 
lower prevalence would be an expected fall in risk behaviour since the introduction of extensive 
harm reduction programmes to Dublin in the early 1990’s. Unfortunately it is difficult to compare 
the risk behaviour rates in the two studies as the time period over which risk behaviour was 
measured was different – the preceding 28 days in Johnson’s study compared with the preceding 
6 months in the present study. The prevalence rate in our study may be a better estimate of HIV 
prevalence in Dublin as the sample size was larger than Johnson’s and the IDU’s were recruited 
from a number of sources both in treatment and out of treatment. 
 The level of HIV prevalence with the levels of risk behaviour show the potential for spread 
of H.I.V. and indicates that much work is yet to be done to attempt to minimise the spread of HIV 
within Ireland. 
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